Immunotherapy vs. Targeted Therapy for Liver Cancer

Liver cancer treatments have advanced over the last few decades. While at first, chemotherapy was the main treatment available, in recent years, a new class of drugs called targeted agents were developed to treat liver cancer. 

When targeted therapies are combined with other newer medications called immunotherapy drugs, there’s usually an even better result in fighting liver cancer that has reached more advanced stages (but treatment outcomes vary for everyone).

Why trust our experts?

Written by:

Marisa Taylor Karas

Marisa Taylor Karas is a freelance journalist based in Brooklyn who has covered health, gender, and technology for 15 years. She previously worked at The Wall Street Journal, The Guardian, and Al Jazeera America, among other publications, and also served as managing editor of the Mellon Foundation in New York City.

Reviewed by:

Alexandra Schwarz, MD

Dr. Schwarz is board eligible Sleep Medicine and board certified Family Medicine physician. She is a member of the AASM and ABFM.

Our editorial standards

Meet our experts